首页> 外文期刊>Alimentary pharmacology & therapeutics. >Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire.
【24h】

Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire.

机译:针对胃食管反流疾病的疾病特定生活质量调查表的开发和验证:GERD-QOL调查表。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: A simple and meaningful health-related quality of life (HRQoL) questionnaire for gastro-oesophageal reflux disease (GERD) patients is lacking. AIM: To develop and validate a disease-specific HRQoL instrument (GERD-QOL) for GERD patients. METHODS: An 18-item questionnaire was generated to measure the impact of GERD on sleep, exercise, diet, need for medication, sex life, work, social activity and psychological well-being. GERD patients were invited to complete the GERD-QOL, a visual analogue scale (VAS) and a validated Chinese generic QoL (SF-36) questionnaire before and after esomeprazole treatment. Factor analysis was performed for item selection and psychometric properties were measured. An English version was developed by a forward-backward translation process. RESULTS: A final 16-item GERD-QOL questionnaire was developed. The items were grouped into four subscales (Daily activity, Treatment effect, Diet, and Psychological well-being) after factor analysis. GERD-QOL had good item-internal consistency (Cronbach's alpha: 0.64-0.88), high test-retest reliability (intraclass correlation coefficient: 0.73-0.94, P < 0.001). Its subscale scores were correlated with SF-36 and VAS, which demonstrated high construct validity (P < 0.001). Discriminant validity was verified by correlating GERD-QOL scores with symptom severity (P < 0.001). Responsiveness after esomeprazole treatment was significant (paired-t-test P < 0.001). An English version of GERD-QOL was developed. CONCLUSION: The instrument, GERD-QOL, is valid and reliable.
机译:背景:缺乏针对胃食管反流病(GERD)患者的简单且有意义的健康相关生活质量(HRQoL)调查表。目的:为GERD患者开发和验证一种针对疾病的HRQoL仪器(GERD-QOL)。方法:生成了18个项目的问卷,以衡量GERD对睡眠,运动,饮食,药物需求,性生活,工作,社交活动和心理健康的影响。埃索美拉唑治疗前后,邀请GERD患者填写GERD-QOL,视觉模拟量表(VAS)和经过验证的中国通用QoL(SF-36)调查表。进行因素分析以选择项目,并测量心理特性。英文版本是通过前后翻译过程开发的。结果:最终的16项GERD-QOL问卷被开发出来。在进行因素分析后,将这些项目分为四个子量表(日常活动,治疗效果,饮食和心理健康)。 GERD-QOL具有良好的项目内部一致性(Cronbach's alpha:0.64-0.88),较高的重测信度(类内相关系数:0.73-0.94,P <0.001)。其子量表得分与SF-36和VAS相关,表明其具有较高的构建效度(P <0.001)。通过将GERD-QOL评分与症状严重程度相关联来验证判别有效性(P <0.001)。埃索美拉唑治疗后的反应性显着(配对t检验P <0.001)。开发了英文版GERD-QOL。结论:GERD-QOL仪器有效可靠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号